BAY-39-5493

N/A

Report date: 2023/11/24 17:18:10
NME

Base Information

Drug NameBAY-39-5493
Drug Alias NameBAY-39-5493
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein modulators
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A